AVCTF
Price
$0.52
Change
-$0.00 (-0.00%)
Updated
Mar 27 closing price
Capitalization
180.85M
KZIA
Price
$3.82
Change
-$0.11 (-2.80%)
Updated
May 2 closing price
Capitalization
4.27M
Ad is loading...

AVCTF vs KZIA

Header iconAVCTF vs KZIA Comparison
Open Charts AVCTF vs KZIABanner chart's image
Avacta Group
Price$0.52
Change-$0.00 (-0.00%)
Volume$8K
Capitalization180.85M
Kazia Therapeutics
Price$3.82
Change-$0.11 (-2.80%)
Volume$48.47K
Capitalization4.27M
AVCTF vs KZIA Comparison Chart
Loading...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCTF vs. KZIA commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCTF is a Hold and KZIA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (AVCTF: $0.52 vs. KZIA: $3.82)
Brand notoriety: AVCTF and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVCTF: 150% vs. KZIA: 102%
Market capitalization -- AVCTF: $180.85M vs. KZIA: $4.27M
AVCTF [@Biotechnology] is valued at $180.85M. KZIA’s [@Biotechnology] market capitalization is $4.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCTF’s FA Score shows that 0 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • AVCTF’s FA Score: 0 green, 5 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, AVCTF is a better buy in the long-term than KZIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KZIA’s TA Score shows that 6 TA indicator(s) are bullish.

  • KZIA’s TA Score: 6 bullish, 2 bearish.

Price Growth

AVCTF (@Biotechnology) experienced а 0.00% price change this week, while KZIA (@Biotechnology) price change was +4.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCTF($181M) has a higher market cap than KZIA($4.27M). AVCTF YTD gains are higher at: -7.965 vs. KZIA (-56.836).
AVCTFKZIAAVCTF / KZIA
Capitalization181M4.27M4,239%
EBITDAN/A-26.77M-
Gain YTD-7.965-56.83614%
P/E RatioN/AN/A-
RevenueN/A2.31M-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
KZIA: Fundamental Ratings
KZIA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KZIA
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDEGX13.760.32
+2.38%
BlackRock Unconstrained Equity Inv A
TISDX11.320.23
+2.07%
Transamerica Intl Sust Eq A
LGCFX17.220.31
+1.83%
Lord Abbett Global Equity F
PMYTX41.470.61
+1.49%
Putnam Core Equity Fund R6
MMFYX16.030.22
+1.39%
MassMutual Equity Opports Svc

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and PTN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and PTN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
N/A
PTN - AVCTF
30%
Poorly correlated
-0.05%
KZIA - AVCTF
26%
Poorly correlated
-2.80%
PHMMF - AVCTF
20%
Poorly correlated
N/A
BETRF - AVCTF
15%
Poorly correlated
+1.43%
AURX - AVCTF
11%
Poorly correlated
-2.45%
More

KZIA and

Correlation & Price change

A.I.dvisor tells us that KZIA and CLNN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KZIA and CLNN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
-2.80%
CLNN - KZIA
33%
Poorly correlated
-0.67%
AMLX - KZIA
30%
Poorly correlated
+3.50%
RVMD - KZIA
29%
Poorly correlated
+0.20%
SGMO - KZIA
27%
Poorly correlated
-1.74%
AVCTF - KZIA
26%
Poorly correlated
N/A
More